Loading company…
Riskpilot
← Back to search
Sign in
Get full access
CSL PHARMA-ADVICE ApS
APS
Dissolved
CVR 36501693
Birkevej 4
Virksomhedsrådgivning og anden rådgivning om driftsledelse · NACE 702200
Est. 2015
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2022
DKK 0
EBITDA margin
—
+188% vs 2021
Equity ratio
95.3%
Financial strength
Net profit 2022
DKK 32K
+173% vs 2021
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2015
0M
0%
2016
0M
0%
2017
0M
0%
2018
0M
0%
2019
0M
0%
2020
0M
0%
2021
0M
0%
2022
Key figures
Annual report 2022
Revenue
DKK 0
—
EBITDA
DKK 31K
+188%
Net profit
DKK 32K
+173%
Total assets
DKK 141K
-49%
Equity
DKK 134K
-50%
Employees
—
—
Company information
Legal name
CSL PHARMA-ADVICE ApS
CVR number
36501693
Legal form
Anpartsselskab
NACE code
702200 · Virksomhedsrådgivning og anden rådgivning om driftsledelse
Founded
27. januar 2015
Share capital
DKK 50.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen.
Contact
Address
Birkevej 4
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Virksomhedsrådgivning og anden rådgivning om driftsledelse
Companies in Lejre
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2015
0M
2016
0M
2017
0M
2018
0M
2019
0M
2020
0M
2021
0M
2022
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2015
0M
2016
0M
2017
0M
2018
0M
2019
0M
2020
0M
2021
0M
2022
Income statement
DKK thousands
Item
2015
2016
2017
2018
2019
2020
2021
2022
Revenue
155
249
404
400
261
143
0
0
Staff expenses
-0
-0
-0
-0
-0
-0
-0
-0
EBITDA
151
189
337
281
181
95
-35
31
Depreciation & amort.
-0
-0
-0
-0
-0
-0
-0
-0
EBIT
151
189
337
281
181
95
-35
31
Net financials
0
0
-1
-0
-3
-3
-10
-2
Profit before tax
151
189
336
280
177
92
-45
32
Tax
36
44
74
66
43
21
-0
-0
Net profit
114
145
262
214
135
71
-45
32
Balance sheet
DKK thousands
Item
2015
2016
2017
2018
2019
2020
2021
2022
Total assets
219
374
701
590
556
450
277
141
Equity
164
309
571
546
480
421
266
134
Long-term debt
0
0
0
0
0
0
0
0
Short-term debt
55
65
130
44
75
29
10
7
Total debt
55
65
130
44
75
29
10
7
Financial ratios
5-year trend
EBITDA margin
3060400.0%
This company
15.8%
Market median
+19369520% vs market
2015
2022
Equity ratio
95.3%
This company
38.2%
Market median
+149% vs market
2015
2022
Return on equity
24.3%
This company
18.4%
Market median
+32% vs market
2015
2022
Net profit margin
3249600.0%
This company
8.1%
Market median
+40118419% vs market
2015
2022
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2015
2022
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
2015
2022
Annual reports & filings
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
View
PDF
Annual report 2016
Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
View
PDF
Annual report 2015
Filed via CVR / Virk · Period 2015-01-27 – 2015-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Claus Selch Larsen
Individual
100.0%
100.0%
2015
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of CSL PHARMA-ADVICE ApS also hold positions in
0
other companies.
Person
Role here
Other companies